-
Italy Claims Curling Silver at European Championships in Ostrava
-
Indian crude-sensitive shares gain after 13% oil-price decline
-
Kuwait finance minister holds economic cooperation talks at COMCEC
-
Stocks and dollar fall as Democratic election gains reshape markets
-
Abdul El-Sayed declares victory in Michigan Senate contest
-
Kuwait marks key events and anniversaries from national history
-
Democrats Seize Congress in Midterm Sweep, Ending Trump Era Control
-
Democrats capture US Congress in sweeping midterm victory
-
Trump congratulates Democrats and signals willingness to cooperate
-
Manchester United rallies past Roma as PSG dominates in Champions League
-
Enel to Install Solar Panels at Niterói Waste Management Facility
-
Qatar prime minister advances mediation through diplomatic calls
-
Qatar sees tentative opening for renewed regional diplomacy
-
Greenland parliament approves security agreement with United States
-
Qatar Tourism joins Pacific Asia Travel Association at London travel market
-
Qatar envoy meets incoming UN General Assembly president
-
Abdul El-Sayed Wins Michigan Senate Seat in Historic Election
-
Trump Signals Willingness to Work With Democrats After Midterm Defeat
-
Qatar media bodies discuss support for humanitarian initiatives
-
How Are Your Wound Centers Doing Today? Wound Care Advantage's New AI Huddle Answers Before Clinic Opens
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 04
-
ShelfieTech Announces Closing of Acquisition of Majority Interest in Aspect
-
Facet Welcomes Three-Time PGA Tour Winner Ben Griffin as Newest Brand Partner
-
Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
-
InstaLILY Research Finds One in Six Leaders Across the Supply Chain Faced an AI Incident Involving Supplier or Customer Data
-
Dolphin to Host Third Quarter 2026 Earnings Conference Call on Nov 10, 2026
-
Wipeboard Family Launches Free AI Chore Planner That Builds Age-Appropriate Chore Plans in Seconds
-
Medical Care Technologies Inc. (OTCID:MDCE) Moves $250,000 Software Agreement Into Active Development
-
PAVS Subsidiary 2Lab3 Launches AniMano+, an AI-Native Digital Entertainment Streaming Platform, on the Apple App Store
-
LightPath Technologies to Host First Quarter Fiscal 2027 Earnings Call on November 10 at 5:00 p.m. Eastern Time
-
Ondas Secures Multi-Million-Dollar Counter-UAS Contracts in Europe and Asia, Accelerating Global Expansion in Aerial Defense
-
QualSights Secures $5 Million Financing and Appoints Prasanna Pitale CEO to Accelerate Company Growth
-
Sidney Resources Secures Federal Approval for Historic Gold and Silver Ore Mobilization
-
Adcore to Publish Third Quarter 2026 Results on November 10, 2026
-
IRS Postpones Texas Tax Deadlines to February 1, 2027 After July Storms - Clear Start Tax Explains What a Disaster Postponement Does Not Pause
-
Dateline and US Government Seek Ninth Circuit Stay
-
Wedgewood Weddings Expands to Maryland With Grey Rock Mansion
-
Worksport Signs Term Sheet to Acquire U.S. Manufactured Truck Bed Accessory Business & Accompanying IP Portfolio
-
Jumia to Announce Third Quarter 2026 Results on November 18, 2026
-
First Canadian Graphite Inc. Closes Flow-Through Financing
-
Apollo Wellness Centers Releases Primer Video
-
RSI Welcomes The Orange County Comptroller's Office as Its Newest Government Premier Partner
-
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study
-
SMX -- Good Intentions Don't Count; Measured Plastic Does
-
Cubic DTECH to Demonstrate Intelligent Mission Infrastructure at The Airlift/Tanker Association's 58th Annual Air Mobility Symposium & Technology Exposition
-
SMX: Recycled Plastic is the Affordability Solution Hiding in Plain Sight
-
New FarmBot Tech Research Finds US Precision Agriculture Use Fell From 27% to 22% as Farm Bankruptcies Rose 46%
-
No Visa Required: SMX Passport Moves Physical Assets into the Digital Economy
-
Live Wildly and the Trust for Public Land Congratulate Florida Voters for Big Election Wins that Protect Healthy Lands and Waters
-
Made in America is Back; SMX Has the Receipts
Semenya faces 'important day' at European rights court
Caster Semenya said Wednesday's hearing at the European Court of Human Rights (ECHR) into whether the double Olympic champion can be required to lower her testosterone levels to compete was an "important day" as her costly legal marathon entered its last lap.
The 33-year-old runner won an earlier round at the ECHR, which last July ruled she was the victim of discrimination from the Lausanne-based Court of Arbitration for Sport (CAS).
"This is an important day in my journey as a human being and athlete. It has been a long time coming," said Semenya, who was the Olympic 800m champion in 2012 and 2016 and world gold medallist in 2009, 2011 and 2017.
"In 2009 I stood atop the podium at the Berlin world championships having just been sex tested and knowing that the world was judging my body and questioning my sex. In the 15 years since then I have persevered with dignity in the face of oppression.
"The adversity I have overcome has helped shaped me into a true champion and a compassionate mother, wife, sister, and daughter.
"I hope that the Court's decision will pave the way for all athletes' human rights to be fiercely protected, for once and for all, and inspire all young women to be and accept themselves in all their diversity."
Semenya, who is classed as having "differences in sexual development (DSD)" but has always been legally identified as female, has refused to take drugs to reduce her testosterone levels since track and field's governing body World Athletics introduced its original rules in 2018.
CAS ruled against her in 2019 and the decision was validated by the Swiss Federal Court in Lausanne in 2020. It declared "fair competition" a "cardinal principle of sport" and said that a testosterone level comparable to that of men gave female athletes "an insurmountable advantage".
- 'Lived as the woman she is' -
Last July, a seven-member ECHR panel ruled, by four votes to three, that the Swiss court's decision constituted discrimination and a violation of Semenya's privacy.
The decision was largely symbolic as it did not call into question the World Athletics ruling nor pave the way for Semenya to return to competition without taking medication.
Swiss authorities, supported by World Athletics, appealed to the European court's 17-member Grand Chamber. Its ruling is not expected for several months but will be binding.
Semenya's lawyer, Schona Jolly, said her client had "lost years of her career awaiting a final determination".
"What this Court says will impact profoundly on her personal and professional life, and indeed, the lives and dignity of many other international sports women."
Semenya, Jolly said, "was forced into illusion of choice, either to safeguard her personal integrity and dignity, and yet be excluded from competing as an elite athlete in the exercise of her profession, or as a healthy woman and athlete to undergo a harmful, unnecessary and supposedly corrective medical treatment".
"Miss Semenya is a woman," Jolly added. "She was assigned the female sex on birth, legally and factually. She has always lived as the woman she is."
Last year, World Athletics altered its rules. DSD athletes like Semenya now have to reduce their amount of blood testosterone to below 2.5 nanomoles per litre, down from the previous level of five, and remain below this threshold for two years.
World Athletics also removed the principle of restricted events for DSD athletes, meaning that they are barred from all distances unless they meet the testosterone criteria.
M.White--AT